BECTON, DICKINSON AND COMPANY Segment Reporting Information, Expenditures for Additions to Long-Lived Assets (Deprecated 2011-01-31)
BECTON, DICKINSON AND COMPANY (BDX) reported Segment Reporting Information, Expenditures for Additions to Long-Lived Assets (Deprecated 2011-01-31) of $537.31 million for the 12-month period ending 2010-09-30, per its 10-K filed 2010-11-24.
Discontinued › Notes › Segment Reporting
us-gaap:SegmentReportingInformationExpendituresForAdditionsToLongLivedAssets · last filed 2010-11-24
- BECTON, DICKINSON AND COMPANY segment reporting information, expenditures for additions to long-lived assets (deprecated 2011-01-31) for fiscal 2010 was $537.31M, a 8.18% decline from fiscal 2009.
- BECTON, DICKINSON AND COMPANY segment reporting information, expenditures for additions to long-lived assets (deprecated 2011-01-31) for fiscal 2009 was $585.20M, a 1.78% decline from fiscal 2008.
- BECTON, DICKINSON AND COMPANY segment reporting information, expenditures for additions to long-lived assets (deprecated 2011-01-31) for fiscal 2008 was $595.81M.
| Period end | Segment Reporting Information, Expenditures for Additions to Long-Lived Assets (Deprecated 2011-01-31) 12 month |
|---|---|
| 2010-09-30 | $537.31M 10-K · filed 2010-11-24 |
| 2009-09-30 | $585.20M 10-K · filed 2010-11-24 |
| 2008-09-30 | $595.81M 10-K · filed 2010-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |